ライフサイエンスコーパス: incremental

1 the field are largely empirically driven and incremental.

2 PT and evaluate the safety of our 30 minutes incremental 1-day protocol.

3 s work establishes Rosetta-guided design and incremental aaRS improvement as a viable and accessible

4 ove toward radically positive change and not incremental adjustments to the status quo.

5 This prompted us to question the effect of incremental [ADP] on respiration in interscapular brown

6 tance of long-term projects characterized by incremental advances involving multiple laboratories can

7 ty-four-hour BP phenotypes conferred a small incremental advantage over clinic BP in predicting cardi

8 ng dried specimens only was dominated in the incremental analysis, due primarily to fewer correct res

9 mal expansion in Asgard and Eukarya has been incremental and iterative, without substantial remodelin

10 advances in improving HB catalysts have been incremental and slow.

11 uster crossover trial of conventional versus incremental antibiotics.

12 ach identifies opportunities to reliably use incremental approaches, enabling adaptation investments

13 PG and PPI responses were calculated as mean incremental area under the curve divided by time.

14 Ethanol-free PPE decreased the incremental area under the curve for glucose (p = 0.019)

15 lated 30-minute (early phase) and 180-minute incremental area under the curves were calculated as res

16 ch, overall postprandial hyperglycemia (24-h incremental area under the glucose curve) and glycemic v

17 excursions) were reduced with the LCBF (24-h incremental area under the glucose curve: -173 +/- 361 m

18 1.6 compared with 26.8 +/- 3.5 nmol x min/L) incremental area-under-the-curve and delayed gastric-emp

19 We assessed the incremental association of metrics achieved with in-hosp

20 During the OGTT the incremental AUC for glucose from postinfusion baseline (

21 Incremental baseline grades of DD were associated with a

22 Results Intraoperative MRI yielded an incremental benefit of 0.18 QALYs (1.34 QALYs with intra

23 however, there is a lack of evidence showing incremental benefit over transthoracic echocardiography.

24 conflicting results and could not confirm an incremental benefit to PWI.

25 ese treatments, with only marginal to modest incremental benefits using conventional cytotoxic therap

26 sus 0.68 [0.48-0.96], p < 0.001), suggesting incremental benefits with an extended intervention.

27 sthma, portal access and CHWs produced small incremental benefits.

28 eal the porosity and tortuosity changes with incremental calendering steps.

29 In 2020, the incremental carbon emission is expected to reach 130.03-

30 Maximum incremental cardiopulmonary exercise tests were performe

31 Incremental CCF change was associated with shorter survi

32 We estimated incremental changes in diabetes mellitus and cardiovascu

33 We show that CHD risk can be lowered with incremental changes in lifestyle and diet, e.g. fruit-ve

34 Incremental changes in PRF and GrB percent expression an

35 Cancer is driven by incremental changes that accumulate, eventually leading

36 Because forest growth is slow and incremental, changes in the carbon density in forest bio

37 the NCI-NCL and EUNCL multi-step approach of incremental complexity to measure particle size distribu

38 = 4, ~50 kg) for 20 procedures guided by 246 incremental conventional CT scans (mean, 12.5 scans per

39 A Markov model was used to determine the incremental cost and effectiveness of extending Medicare

40 thirty-year reductions in TB incidence, and incremental cost effectiveness (cost per quality-adjuste

41 ental cost-effectiveness ratio (ICER) as the incremental cost in dollars per quality-adjusted life ye

42 analysis model was developed to estimate the incremental cost needed to obtain an additional response

43 0.47-1.75) quality-adjusted life-years at an incremental cost of $1 135 000 (872 000-1 377 000), resu

44 raoperative MRI vs 1.16 QALYs without) at an incremental cost of $13 447 ($176 460 with intraoperativ

45 iveness gain of 2.98 QALY justified a higher incremental cost of $2085.00.

46 d ibrutinib arm, first-line ibrutinib had an incremental cost of $478 823, an incremental effectivene

47 d to significantly higher health care costs (incremental cost of $612 700), resulting in an ICER of $

48 e interval [CI], $331-$347), resulting in an incremental cost of the intervention of US$77 (95% CI, $

49 rmittent preventive treatment resulted in an incremental cost of US$5657 (95% CI 1827 to 9448) and 10

50 (95% credibility interval 274 to 1517) at an incremental cost of US$7051 (2653 to 13 038) generating

51 Results are presented as the incremental cost per DALY averted and the likelihood tha

52 The main outcome measure was the incremental cost per DALY averted.

53 The incremental cost per pain-free patient are savings of &O

54 Incremental cost per quality-adjusted life-year (QALY) w

55 ted life expectancy compared with GDMT at an incremental cost per quality-adjusted life-year gained t

56 Incremental cost to the NHS per 1,000-step increase per

57 The incremental cost was similar when analysis was restricte

58 Incremental cost-effectiveness analysis demonstrates tha

59 We did an incremental cost-effectiveness analysis using data from

60 Using Kenya as a case study, we assessed the incremental cost-effectiveness of continuing PCV use.

61 The incremental cost-effectiveness of implementing SA PC 101

62 We aimed to estimate the incremental cost-effectiveness of intermittent preventiv

63 The primary outcome was the incremental cost-effectiveness of point-of-care Xpert re

64 ared with screening at ages 10 and 20 years (incremental cost-effectiveness ratio $106 841/quality-ad

65 py alone in all groups considered (base case incremental cost-effectiveness ratio $39,800).

66 With an incremental cost-effectiveness ratio >$200 000/QALY gain

67 obability that PCDT would achieve a lifetime incremental cost-effectiveness ratio <$50 000/QALY or <$

68 The primary outcome measure was the incremental cost-effectiveness ratio (discounted US$ per

69 ffectiveness was determined by measuring the incremental cost-effectiveness ratio (ICER) as the incre

70 tal quality-adjusted life years (QALYs), and incremental cost-effectiveness ratio (ICER) at willingne

71 n-fatal stroke) over a 5-year period and the incremental cost-effectiveness ratio (ICER) from the per

72 onsensus exists about what threshold for the incremental cost-effectiveness ratio (ICER) in dollars p

73 Strategies with an incremental cost-effectiveness ratio (ICER) less than th

74 At 20% coverage, DAAs had an incremental cost-effectiveness ratio (ICER) of $27 251/q

75 st of US$7051 (2653 to 13 038) generating an incremental cost-effectiveness ratio (ICER) of $8 (2 to

76 showed that compared with no treatment, the incremental cost-effectiveness ratio (ICER) of DAAs at a

77 Strategies with incremental cost-effectiveness ratio (ICER) of less than

78 The incremental cost-effectiveness ratio (ICER) was calculat

79 service care cost per life-year saved as the incremental cost-effectiveness ratio (ICER), based on 20

80 Incremental cost-effectiveness ratio (ICER), expressed a

81 The primary outcome measure was the incremental cost-effectiveness ratio (ICER).

82 of FLU+5FC vs FLU alone was measured as the incremental cost-effectiveness ratio (ICER).

83 years (QALYs), total cost (in 2018 US$), and incremental cost-effectiveness ratio (ICER; from the hea

84 FujiLAM was considered cost-effective if its incremental cost-effectiveness ratio (USD/year-of-life s

85 cost of $31,156 (95% CI, -$158 to $92,179) (incremental cost-effectiveness ratio = $38,648 per quali

86 ost of $5,242 (95% CI, -$19,035 to $41,019) (incremental cost-effectiveness ratio = $44,615 per extra

87 t effective for all international travelers (incremental cost-effectiveness ratio [ICER] $4.6M/measle

88 curacy 96%, $196 per patient) and long term (incremental cost-effectiveness ratio [ICER] $5,387-$8,43

89 nth testing was cost-effective for both MSM (incremental cost-effectiveness ratio [ICER], $1000/year

90 The main outcomes were lifetime incremental cost-effectiveness ratio and annual budget i

91 Cost-effectiveness was evaluated using the incremental cost-effectiveness ratio and net monetary be

92 The primary outcome was the incremental cost-effectiveness ratio assessed from the U

93 Model inputs with the greatest variation on incremental cost-effectiveness ratio estimates were the

94 The incremental cost-effectiveness ratio for 1 week of AmB a

95 The incremental cost-effectiveness ratio for catheter ablati

96 Sensitivity analyses show that the incremental cost-effectiveness ratio is sensitive to the

97 SGA had a 64% to 77% likelihood of having an incremental cost-effectiveness ratio of $100 000 or less

98 net monetary benefit of AUD$1.02 million and incremental cost-effectiveness ratio of $4,684 per QALY

99 rs at a cost of $45 648, yielding a lifetime incremental cost-effectiveness ratio of $40 361 per life

100 $4,949 increase in 1-year care costs, and an incremental cost-effectiveness ratio of $42,120 per qual

101 monetary benefit of AUD$1.02 million and an incremental cost-effectiveness ratio of $4684 per QALY g

102 in microsimulation modeling, resulting in an incremental cost-effectiveness ratio of $76 442 per QALY

103 135 000 (872 000-1 377 000), resulting in an incremental cost-effectiveness ratio of $880 000 (697 00

104 s (95% CI, 0.23-0.86) longer survival for an incremental cost-effectiveness ratio of $9392.

105 10 (US$237.36) per patient at 1 year, and an incremental cost-effectiveness ratio of approximately po

106 891]) compared with DM, resulting in a mean incremental cost-effectiveness ratio of euro 27 023 ($29

107 0 and costs by euro 670 million, yielding an incremental cost-effectiveness ratio of euro 9,600/QALY.

108 The incremental cost-effectiveness ratio of high bundle adhe

109 The incremental cost-effectiveness ratio of POC assays versu

110 interval [CI] 0.67-0.99, p = 0.017) with an incremental cost-effectiveness ratio of pound 1,359 per

111 produced higher total QALYs and costs and an incremental cost-effectiveness ratio of pound 110 741/QA

112 red with methotrexate alone, resulting in an incremental cost-effectiveness ratio of pound 129 025 pe

113 The base case incremental cost-effectiveness ratio of the antibacteria

114 Cost-effectiveness estimates showed an incremental cost-effectiveness ratio of US$13.0 per disa

115 their stable partners over 10 years, with an incremental cost-effectiveness ratio of US$509 per DALY

116 The incremental cost-effectiveness ratio ranged from 28 500

117 The incremental cost-effectiveness ratio remained lower than

118 The incremental cost-effectiveness ratio was $36,001/quality

119 -719.7 to 904.1) per 1000 women; the average incremental cost-effectiveness ratio was $53 per DALY av

120 tality (hazard ratio of 0.86), the estimated incremental cost-effectiveness ratio was $74 403 per QAL

121 The incremental cost-effectiveness ratio was calculated and

122 calculated and the empirical 95% CI for the incremental cost-effectiveness ratio was estimated from

123 treatment cost of US$5,850, the mean overall incremental cost-effectiveness ratio was US$92,200 per Q

124 The primary outcome was the incremental cost-effectiveness ratio.

125 HV centers was determined by calculating the incremental cost-effectiveness ratio.

126 nal $500/person, and was not cost-effective (incremental cost-effectiveness ratio: $420 000/quality-a

127 d total implementation costs; and determined incremental cost-effectiveness ratios (ICER) and benefit

128 al-days, and costs over 180-days, as well as incremental cost-effectiveness ratios (ICER, $/quality-a

129 We calculated incremental cost-effectiveness ratios (ICERs) and assess

130 We calculated incremental cost-effectiveness ratios (ICERs) and report

131 Incremental cost-effectiveness ratios (ICERs) are report

132 ID, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs) for each c

133 l diversion program and calculated resulting incremental cost-effectiveness ratios (ICERs) from the h

134 ealthcare, and lost-productivity costs), and incremental cost-effectiveness ratios (ICERs) of two pol

135 We assessed mean incremental cost-effectiveness ratios (ICERs) under a wi

136 effectiveness was assessed by calculation of incremental cost-effectiveness ratios (ICERs) using net

137 ICURs) using quality-adjusted life-years and incremental cost-effectiveness ratios (ICERs) using year

138 ts, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) were calcu

139 Incremental cost-effectiveness ratios (ICERs) were compa

140 Results are presented as incremental cost-effectiveness ratios (ICERs), defined a

141 lity-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios (ICERs).

142 sted life-years (QALYs), lifetime costs, and incremental cost-effectiveness ratios (ICERs).

143 ts, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs).

144 quality-adjusted life expectancy, costs, and incremental cost-effectiveness ratios (ICERs, $/quality-

145 ortive care in the German model resulting in incremental cost-effectiveness ratios for cabozantinib o

146 The incremental cost-effectiveness ratios for PLA were INT$3

147 We judged incremental cost-effectiveness ratios of $1010 (Zimbabwe

148 tinib and $4630 for best supportive care and incremental cost-effectiveness ratios of $972,049/life y

149 Reported incremental cost-effectiveness ratios ranged from -$119,

150 Among patients with LDL-C >=100 mg/dl, incremental cost-effectiveness ratios remained below US$

151 benefits and result in substantially higher incremental cost-effectiveness ratios than the current r

152 Incremental cost-effectiveness ratios were calculated to

153 ality-adjusted life years (QALYs), cost, and incremental cost-effectiveness ratios were estimated for

154 senting cost per quality-adjusted life year, incremental cost-effectiveness ratios, or cost per life-

155 ts; quality-adjusted life years (QALYs); and incremental cost-effectiveness ratios.

156 ermined by calculating CLABSIs prevented and incremental cost-effectiveness ratios.

157 s), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios.

158 treated, and cured; cirrhosis cases avoided; incremental cost-effectiveness ratios; DOC costs (2016 U

159 ed included varicella and HZ incidences, the incremental cost-utility ratio (ICURs) over a lifetime h

160 e strategy of extending drug coverage had an incremental cost-utility ratio of $51,694 per QALY gaine

161 A decision tree was generated and incremental cost-utility ratios (ICUR) were calculated.

162 Main outcomes were incremental cost-utility ratios (ICURs) using quality-ad

163 arly 3-fold more CRC deaths at one third the incremental cost.

164 eneralized linear model was used to estimate incremental costs (2016 U.S. dollars) and quality-adjust

165 Cost-effectiveness was measured as incremental costs per life-year saved, and non-parametri

166 ost-effectiveness ratios (ICERs), defined as incremental costs per quality-adjusted life year (QALY)

167 een the short- and long-term storage groups (incremental costs, -$2,358; 95% CI, -$5,586 to $711) and

168 Progressive EBL cohorts displayed incremental CR-POPF rates (8.5%, 13.4%, 15.2%, 16.9%; P

169 ive compared to bevacizumab ($1,151,451/QALY incremental CUR).

170 r pulmonary function and performed a maximal incremental cycle exercise test.

171 t of US$5657 (95% CI 1827 to 9448) and 107.4 incremental DALYs averted (-719.7 to 904.1) per 1000 wom

172 we describe requirements for a framework for incremental data integration and propose an implementati

173 ome clinical samples and cataloging them in "Incremental Databases" that maintain individual confiden

174 esent different "strategies", for example an incremental, decremental, or counting strategy.

175 We therefore aimed to determine the incremental diagnostic yield (ie, the added value) of WE

176 n and to characterize subclinical AF and the incremental diagnostic yield of 4 versus 2 weeks of cont

177 The incremental diagnostic yield of reflexing to trio after

178 nitoring beyond 2 weeks provided substantial incremental diagnostic yield.

179 22,057 versus GBPpound 26,286 respectively, incremental difference GBPpound 4,229).

180 DBT screening led to incremental discounted lifetime effects of 5.09 LYGs (95

181 = 0.02) and antibody responses (P = 0.01) at incremental doses before versus after challenge.

182 ients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) is

183 s and functions in fibroblasts, although its incremental effect on sarcomeric protein induction was r

184 inib had an incremental cost of $478 823, an incremental effectiveness of 0.05 QALYs, and an ICER of

185 During incremental effort exercise in both groups, concentratio

186 ogonal catalysis in biomedicine is inspiring incremental efforts to design strategies that regulate d

187 d T(H)17 cell-related mediators demonstrated incremental elevations with increasing disease severity,

188 The participants performed an incremental exercise test to volitional exhaustion to de

189 HFrEF patients and controls performed an incremental exercise test to volitional exhaustion to de

190 ix types of feature encoding schemes through incremental feature selection and application of the XGB

191 s between the CGM devices according to their incremental glucose response.

192 ottom compared with those in the top half of incremental glycemic responses ranked by Abbott resulted

193 Within-subject meal rankings for incremental glycemic responses were relatively discordan

194 evels of 2.8 mmol/L (50 mg/dl) for 1 hour by incremental hyperinsulinemic clamps using baseline and 2

195 ment durations and washout periods to assess incremental improvement in airway hyperresponsiveness wh

196 The incremental improvement in plane flight distance in the

197 Surgical innovation ranges from minor incremental improvement to radical experimentation.

198 ergetics models for shark and ray megafauna, incremental improvements in respirometry systems are use

199 One-point incremental increase in pre-operative D-MELD (adjusted H

200 The incremental increase in the incidence rate for migraine

201 igh-calorie delivery were associated with an incremental increase in the likelihood or mortality.

202 dies against neuronal proteins has led to an incremental increase in use of the term "autoimmune epil

203 This work demonstrates the effects of an incremental increase of nanopillar height on nanostructu

204 s shown to be sustained, and KT displayed an incremental increase over time.

205 Incremental increases in a driver variable, such as nutr

206 le-phase (SP) and two-phase (TP) mode across incremental increases in organic loading rate (OLR) from

207 ovo recruitment or loss; the latter involves incremental increases in the transcriptional elongation

208 643) within 1 month, followed by consecutive incremental increases up to 53% (804 108/1 515 537) by 1

209 tive/radical innovations yet higher rates of incremental innovations; individuals from culturally tig

210 (2) reciprocating needle-cannula motions for incremental insertion.

211 Incremental integration is thus a suitable framework for

212 The sparse thalamic firing could promote an incremental integration of recently acquired memory trac

213 ible neural substrate for seamless real-time incremental interpretation on the observed millisecond t

214 and 8 sheep with pacing-induced HF received incremental intravenous boluses of PDE9-I (30, 100, and

215 eins and minerals that calcify to form a new incremental layer of the exoskeleton.

216 g continual learning benchmarks (e.g., class-incremental learning on CIFAR-100) without storing data,

217 c forgetting on toy examples even in a class-incremental learning scenario.

218 are consistent over time, we then projected incremental long-term gains in event-free survival and o

219 Both baseline and follow-up incremental loop diuretic doses were associated with wor

220 me up to 30 lymph nodes resected and then an incremental loss in lifetime.

221 Injected eyes had an additional incremental loss of -0.385 mum/year, but this value was

222 lows in NPDR and PDR results largely from an incremental loss of capillary segments.

223 d Dexcom systems resulting in within-subject incremental mean +/- SD glucose CVs of 91.7 +/- 1.9% and

224 multilevel random effects models to estimate incremental mean costs and outcomes.

225 enefit and harm, the benefit-risk ratio, and Incremental Net Benefit.

226 dates and grant applications - words such as incremental, novelty, mechanism, descriptive and impact

227 h only 0.1 wt% of E-CNS in brine resulted in incremental oil production of 20%, highlighting the sign

228 concerns, and the interest in the associated incremental or decremental problems.

229 were most sensitive to test volume, whereas incremental outcomes were most sensitive to the number o

230 Quantitative CT measures added incremental predictive value beyond a model with only cl

231 Ang 1-7/Ang II ratio, as an independent and incremental predictor of beneficial outcomes, higher sur

232 d with increasing exposure duration, with an incremental prevalence increase of 8.2% per 250 exposure

233 It is therefore an appropriate incremental procedure with no exclusion criterion for an

234 DENSE-derived strain provided incremental prognostic benefit over infarct size for pre

235 erative secretoneurin concentrations provide incremental prognostic information to established risk i

236 The epsilon(s) yielded incremental prognostic value above left ventricular ejec

237 e left atrial peak reservoir strain provided incremental prognostic value for major adverse cardiovas

238 DI<0.25 showed incremental prognostic value in patients with LG-LF seve

239 al primary PCI, and door-to-balloon time add incremental prognostic value in STEMI care.

240 The incremental prognostic value of each facet of STEMI care

241 This study aimed to evaluate the incremental prognostic value of unrecognized myocardial

242 CT-derived measures have incremental prognostic value over and above clinical par

243 k assessment early after reperfused AMI with incremental prognostic value over and above that of LVEF

244 Each metric provided incremental prognostic value when modeled in stepwise or

245 ficant improvements in model fit, suggesting incremental prognostic value.

246 pancreatic ductal adenocarcinoma, important incremental progress has been made particularly for the

247 grafts by utilizing biodegradable scaffolds, incremental pulsatile stretching, and optimal culture co

248 costs, -$2,358; 95% CI, -$5,586 to $711) and incremental quality-adjusted life years: 0.003 quality-a

249 Applying the 8th edition criteria yielded an incremental reduction in survival for each increase in s

250 initial 'loading' dose followed by doses of incremental reductions in antibiotic quantity (dose 'tap

251 within the posterior inner retina following incremental reductions in arteriovenous perfusion pressu

252 Above the critical point, agents exploit incremental refinements to systematically advance toward

253 ments of the cardiac function in volunteers, incremental respiratory motion parameters that were deri

254 The incremental rise in FT1 expression is overridden in plan

255 f limb events, with no consistent pattern of incremental risk observed with dapagliflozin.

256 al clearance as soon as possible to minimize incremental risk of mortality with each day of positive

257 body surface area), at rest and post maximal incremental running.

258 This incremental settlement process likely involved the accum

259 A shoreline change model driven by incremental SLR (0.25, 0.46, 0.74 m) is used to simulate

260 Recent work has outlined how small incremental steps power cell-autonomous epithelial shape

261 terotrimeric G proteins has been emerging in incremental steps, but attributing biological significan

262 However, the cascading relationship between incremental stress exposure and neural dysfunctions over

263 ared to resection and ablation, the absolute incremental survival benefit is small over a 5-year time

264 However, in absolute terms, the incremental survival benefit of LT over resection or abl

265 ghest with LT, there are limited data on the incremental survival benefit of LT versus other curative

266 ts, the cediranib toxicity profile and small incremental survival benefit precludes additional develo

267 y status, higher HF risk was observed across incremental tertiles of time-varying total SB (hazard ra

268 Similar results were obtained with incremental time abstinent from opioids as an outcome an

269 Imaging biomarkers can play important roles incremental to conventional clinical factors for risk st

270 ischemic stroke in the AF population but not incremental to global longitudinal strains.

271 fibrillation (P<0.001) and was superior and incremental to interleukin-6, C-reactive protein, procal

272 the prognostic value of GLS was superior and incremental to LVEF and CMR markers of infarct severity.

273 ing synchrotron X-ray tomographic imaging of incremental tooth cementum, that they had maximum lifesp

274 Moving from COL to FIT results in an incremental unintended psychological harm of 16 addition

275 The incremental upload and validation of clinical input data

276 In addition, our calculations articulate incremental URF (IURF) of solvent huff'n'puff based on n

277 g conversion from MCI to AD, underlining the incremental utility of (18)F-FDG PET.

278 Whether histology adds incremental value beyond usual donor attributes in asses

279 uring allocation did not provide substantial incremental value in ascertaining organ quality.

280 to bone mineral (K(i)) by PET/CT can provide incremental value in response assessment of bone metasta

281 on for patients with MELD of 30 or less, the incremental value is small.

282 for those with a MELD score greater than 30 (incremental value of 0.31 quality-adjusted life years fo

283 or patients with a MELD score of 30 or less (incremental value of 0.54 and 0.36 quality-adjusted life

284 o better understand the process by which the incremental value of each biomarkers is evaluated to det

285 These findings suggest incremental value of exercise hemodynamic assessment to

286 To determine the incremental value of polygenic risk score (PRS) for coro

287 The incremental value of polygenic risk scores in addition t

288 Furthermore, the incremental value of testing endothelial function has ne

289 What, then, is the incremental value of using more sensitive and specific,

290 Utilization of LA strain further provided incremental value over CHA(2)DS(2)-VASc scoring (C stati

291 nt score or these 2 domains provided similar incremental values ( P=0.0004 and P=0.0008, respectively

292 re with preserved ejection fraction, but the incremental vascular molecular remodeling mechanisms fro

293 Unadjusted mean Medicare payments for each incremental year of patency were as follows: $71 000 for

294 T and 1.1% (95% CI: 0.6-1.7) for RT-PCR; the incremental yield of chest CT was 0.4%.

295 The incremental yield of LAM increased with decreasing CD4 c

296 B-specific test was used as a reference, the incremental yield of LAM over Xpert was 29.6% (45/152) a

297 To determine the incremental yield of standardized addition of chest CT t

298 However, the incremental yield of this strategy is unknown.

299 : To investigate the diagnostic accuracy and incremental yield of Xpert MTB/RIF Ultra (Ultra; Cepheid

300 Incremental Z-score values between -2.5 and 2.5 were cal